• View Cart
  • FAQs
  • LOG IN
Biotech Primer WEEKLY
  • Home
  • Training Options
    • Customized Onsite Training
    • Live, Online 1 & 2-Day Master Courses
    • On-Demand, Online 60-Minute Classes
    • Master Course Recordings
    • Corporate Learning
  • About Us
    • Our Expertise
    • Our Experience
    • Our Clients
    • Contact Us
  • Our Publications
    • The WEEKLY Newsletter
    • 2020 WEEKLY Compendium
    • 2015-2020 Quinquennial
      Compendium
    • Biotech Primer Book
    • Biotech for Non-Scientists Course SnapShot
    • Online Course Snapshot
    • Medical Device Course Snapshot
    • Drug Development Course SnapShot
    • Manufacturing Course SnapShot
Select Page
Stopping A Big Problem: Blood Clots

Stopping A Big Problem: Blood Clots

by Stacey Hawkins | Jul 13, 2017 | Metabolic & Cardiovascular Disease

MEDS FOR THINNER BLOOD CAN EQUAL FEWER CLOTS, BUT HOW?   The FDA’s recent approval of Portola Pharmaceuticals’ (South San Francisco, CA) new blood thinner drug Bevyxxa paved the way for the prevention of blood clots in patients hospitalized for...

About Biotech Primer

From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.

In a hurry? Take our online classes today.

Subscribe to The WEEKLY

Contact Us | Privacy Policy | Biotech Primer © 2021